Grubbs v. Ngbodi, R.N., F.N.P.

CourtDistrict Court, S.D. New York
DecidedSeptember 2, 2022
Docket7:21-cv-02906
StatusUnknown

This text of Grubbs v. Ngbodi, R.N., F.N.P. (Grubbs v. Ngbodi, R.N., F.N.P.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Grubbs v. Ngbodi, R.N., F.N.P., (S.D.N.Y. 2022).

Opinion

USDC SDNY UNITED STATES DISTRICT COURT DOCUMENT SOUTHERN DISTRICT OF NEW YORK NOCH ERED

Plaintiff,

-against- 21-cv-02906 (NSR)

KATIE NGBODI, R.N., F.N.P., LYNN B. ORDER & OPINION WEINRIT, R.N., SANGEETHA L. MUKKATT, R.N., NURSE WHO SERVED AS NURSING PROVIDER #574 at FISHKILL CORRECTIONAL FACILITY, and JOHN AND JANE DOES 1-10, Defendants.

NELSON S. ROMAN, United States District Judge: Plaintiff Bobby Grubbs (‘Plaintiff’), a prisoner in custody of the New York State Department of Corrections and Community Supervision (hereinafter “DOCCS”), brings this action for deliberate indifference to serious medical needs under the Eighth Amendment, pursuant to 42 U.S.C. § 1983 (“Section 1983”) and New York medical malpractice law. Plaintiff asserts each of his claims against the following registered nurses, in their official and individual capacities, who treated Plaintiff at the Fishkill Correctional Facility (together, “Defendants”): (1) Katie Ngbodi, R.N., F.N.P.; (it) Lynn B. Weinrit, R.N.; (11) Sangeetha L. Mukkatt, R.N.; and (iv) an unnamed nurse referred to as “Nurse #574.” Plaintiff also names John and Jane Does 1-10, who were persons in charge of the custodial and/or medical care provided to Plaintiff at relevant times.! (Am. Compl. § 34.)

| Plaintiff alleges that all defendants were “were acting under color of State law and/or as agents, servants, employees, and/or contractors of DOCCS.” (Am. Compl. ¥ 29.)

Now before the Court is Defendants’ motion to dismiss the Amended Complaint for failure to state a claim pursuant to Fed. R. Civ. P. 12(b)(1) and (6). For the following reasons, the motion is GRANTED, and Plaintiff’s claims are dismissed without prejudice. BACKGROUND

The following facts are taken from Plaintiff’s Amended Complaint (ECF No. 21) and are accepted as true for purposes of this motion. Plaintiff is a 52-year old2 African American male who has been in DOCCS custody since around October 8, 2009. (Am. Compl. ¶¶ 1, 37). In July 2020, Plaintiff was diagnosed with Stage IV-B Gleason prostate cancer with metastasis and lymphovascular invasion. (Id.) Plaintiff also received an HIV diagnosis in or around 1997, which requires him to undergo physical examination and bloodwork every 90 days. (Id. ¶ 40.) Plaintiff received a prostate-specific antigen (“PSA”) screening upon being incarcerated under DOCCS custody on or around October 14, 2009, which reflected normal results at 1.890 ng/mL. (Id. ¶¶ 3, 41.) On or about December 31, 2009, Mr. Grubbs was transferred to Great

Meadows Correctional Facility (“Green Meadows”) located in Comstock, New York. (Id. ¶ 42.). While at Green Meadows, in or around 2012, Plaintiff began to experience urinary start-and-stop problems, and made complaints to DOCCS medical staff. (Id. ¶ 4, 42–43.) In or around January 2013, Plaintiff began to be prescribed with a urinary retention medication named Flomax (Tamsulosin) by Dr. David Karandy, M.D., who acted as Plaintiff’s primary care physician at Green Meadows. (Id. ¶ 43.)

2 Plaintiff alleges this was his age at the time of his filing of the Amended Complaint. (Am. Compl. ¶ 1.) Plaintiff received another PSA screening on or around April 16, 2013, which reflected elevated results at 3.80 ng/mL.3 (Id. ¶ 44.) Plaintiff continued to be prescribed Flomax by Dr. Karandy. (Id.) From that point through July 2020, Plaintiff was not offered nor did he receive PSA testing, or any urology care treatment other than being administered Flomax. (Id. ¶¶ 6–7,

45–46.) Plaintiff complained about his urinary issues to DOCCS medical personnel at various facilities he was housed in between 2013 to 2018, including at Great Meadows Correctional Facility, Coxsackie Correctional Facility, Upstate Correctional Facility, Clinton Correctional Facility, and Green Haven Correctional Facility. (Id. ¶ 47.) While residing at Clinton Correctional Facility, Plaintiff filed a grievance that was appealed to the Central Office Review Committee on April 14, 2015, explaining that a prison physician refused to renew Plaintiff’s Flomax prescription, causing him to feel the constant urge to urinate. (Id. ¶ 48.) On or around August 16, 2018, Plaintiff was transferred to Fishkill Correctional Facility (“Fishkill”). (Id. ¶¶ 8, 49.) Plaintiff’s medical and correctional records were also automatically

transferred with him to Fishkill. (Id. ¶¶ 8, 50.) Plaintiff presented himself to the Fishkill infirmary complaining of pain and discomfort in his back and abdomen on several occasions including on: December 24, 2018, when he was examined by Defendant Nurse #574; February 7, 2019, when he was examined by Defendant Ngbodi; April 9, 2019, when he was examined by Defendant Weinrit; April 25, 2019, when he was examined by Defendant Nurse #574; and May 15, 2019

3 Plaintiff states that a PSA level of 4.0 ng/mL is the standard cut-off for indications of cancer and is generally associated with a 25% chance of having prostate cancer. (Am. Compl. ¶¶ 5, 18.) Plaintiff argues that therefore, his 2013 test results “required close monitoring, urology consultation, and periodic surveillance including, at a minimum, annual PSA follow-up tests.” (Am. Compl. ¶ 5.) Plaintiff also cites to a medical literature stating that African American men are at a higher risk of prostate cancer. (Id. ¶ 2, n.1.) In addition, the American Cancer Society Recommendations, which Plaintiff cites to, indicate that “screening should be done yearly for men whose PSA level is 2.5 ng/mL or higher.” (Id. ¶ 2, n.2) (citing American Cancer Society Recommendations for Prostate Cancer Early Detection, accessible at https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/acs- recommendations.html) (last visited on Aug 30, 2022). (when he had to reschedule physical therapy due to stomach discomfort, which request was sent to Defendant Ngbodi). (Id. ¶ 54.) Plaintiff also filed a grievance on or around October 7, 2018 explaining that he complained to Defendant Ngbodi regarding his daily stomach problems. (Id.) During each visit, Defendants prescribed pain medications or physical therapy. (Id. ¶ 55.) Plaintiff was also not given the option to be examined by a physician or urologist.4 (Id.)

On July 30, 2019, Plaintiff met with an unnamed infirmary nurse for abdominal pain aggravated by passing stool. (Id. ¶ 58.) The nurse checked that Plaintiff’s “abdominal sound” was present, suggested that he hydrate, and discharged him to his cell. (Id.) Defendant Ngbodi reviewed this encounter and renewed Plaintiff’s Flomax and Zantac prescriptions. (Id. ¶ 59.) On September 1, 2019, Defendant Nurse #574 requested new prescription scripts for Flomax and Zantac. (Id. ¶ 60.) Defendant Ngbodi ordered and reviewed Mr. Grubbs’ bloodwork, including on September 17, 2018, November 9, 2018, May 1, 2019, September 3, 2019, October 16, 2019, and December 10, 2019. (Id. ¶ 63.) Defendant Ngbodi reviewed these blood lab results each time and signed off

that “[n]o action is required at this time” without a review or co-signature by a physician. (Id.) Defendant Ngbodi did not include PSA testing as part of the test analyses. (Id.) By early 2020, Plaintiff experienced constant sharp pains in his lower abdomen and back as well as urinary retention and difficulty voiding, even though he took Flomax. (Id. ¶ 65.) He also experienced worsening pain when trying to urinate and frequent urges to urinate. (Id.) On January 13, 2020, Plaintiff was seen by Defendant Mukkatt at the infirmary and complained about

4 Plaintiff alleges that his medical records refer to Defendant Ngbodi as his Primary Care Physician, though she is a Family Nurse Practitioner. (Am. Compl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Baker v. McCollan
443 U.S. 137 (Supreme Court, 1979)
Helling v. McKinney
509 U.S. 25 (Supreme Court, 1993)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hill v. Curcione
657 F.3d 116 (Second Circuit, 2011)
Baker v. Coughlin
77 F.3d 12 (Second Circuit, 1996)
Hathaway v. Coughlin
99 F.3d 550 (Second Circuit, 1996)
Chance v. Armstrong
143 F.3d 698 (Second Circuit, 1998)
Natalia Makarova v. United States
201 F.3d 110 (Second Circuit, 2000)
Luckett v. Bure
290 F.3d 493 (Second Circuit, 2002)
In re: Barclays Bank PLC Security
734 F.3d 132 (Second Circuit, 2013)
Gonzalez v. City of Schenectady
728 F.3d 149 (Second Circuit, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Cornejo v. Bell
592 F.3d 121 (Second Circuit, 2010)
Lloyd v. Lee
570 F. Supp. 2d 556 (S.D. New York, 2008)
Stevens v. Goord
535 F. Supp. 2d 373 (S.D. New York, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Grubbs v. Ngbodi, R.N., F.N.P., Counsel Stack Legal Research, https://law.counselstack.com/opinion/grubbs-v-ngbodi-rn-fnp-nysd-2022.